{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:31:57Z","timestamp":1792661517408,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bpa.2020.07.009","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T11:12:31Z","timestamp":1595243551000},"page":"479-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Utilization of B12 for the treatment of chronic migraine"],"prefix":"10.1016","volume":"34","author":[{"given":"Ivan","family":"Urits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melis","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Bahrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Merley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Scoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lassiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vwaire","family":"Orhurhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.mayocp.2017.12.002","article-title":"Diagnosis and management of headache in older adults","volume":"93","author":"Starling","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"S2","key":"10.1016\/j.bpa.2020.07.009_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/head.12505_2","article-title":"Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention","volume":"55","author":"Lipton","year":"2015","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.009_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/head.12482","article-title":"The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies","volume":"55","author":"Burch","year":"2015","journal-title":"Headache"},{"issue":"10053","key":"10.1016\/j.bpa.2020.07.009_bib4","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Kassebaum","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.009_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/head.13281","article-title":"The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies","volume":"58","author":"Burch","year":"2018","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.009_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.24897","article-title":"The burden of neurological disease in the United States: a summary report and call to action","volume":"81","author":"Gooch","year":"2017","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.bpa.2020.07.009_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","article-title":"Chronic migraine: risk factors, mechanisms and treatment","volume":"12","author":"May","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.009_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: epidemiology, burden, and comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol Clin"},{"issue":"Suppl 1","key":"10.1016\/j.bpa.2020.07.009_bib9","article-title":"Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache","volume":"40","author":"Rapoport","year":"2019","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","article-title":"Migraine treatment: current acute medications and their potential mechanisms of action","volume":"15","author":"Ong","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ncl.2008.11.008","article-title":"Acute treatment of migraine","volume":"27","author":"Tepper","year":"2009","journal-title":"Neurol Clin"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.009_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1526-4610.2004.04078.x","article-title":"Consensus statement: cardiovascular safety profile of triptans (5-HT 1B\/1D agonists) in the acute treatment of migraine","volume":"44","author":"Dodick","year":"2004","journal-title":"Headache"},{"issue":"11","key":"10.1016\/j.bpa.2020.07.009_bib14","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1345\/aph.1K121","article-title":"Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis","volume":"41","author":"Suthisisang","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.009_bib15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1526-4610.2010.01635.x","article-title":"Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine","volume":"50","author":"Suthisisang","year":"2010","journal-title":"Headache J Head Face Pain"},{"issue":"9","key":"10.1016\/j.bpa.2020.07.009_bib16","article-title":"Aspirin with or without an antiemetic for acute migraine headaches in adults","volume":"2017","author":"Kirthi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.009_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1526-4610.2012.02293.x","article-title":"Non-steroidal anti-Inflammatories for the acute treatment of migraine","volume":"53","author":"Tepper","year":"2013","journal-title":"Headache J Head Face Pain"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008783.pub2","article-title":"Diclofenac with or without an antiemetic for acute migraine headaches in adults","volume":"2","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.bpa.2020.07.009_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1468-2982.2005.00948.x","article-title":"The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group st","volume":"25","author":"Diener","year":"2005","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.009_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1163\/156856003322699573","article-title":"Mechanisms of action of paracetamol and related analgesics","volume":"11","author":"Graham","year":"2003","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.009_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1468-2982.2003.00690.x","article-title":"Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review","volume":"24","author":"Lipton","year":"2004","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.009_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0165-6147(89)90238-1","article-title":"5-HT1-like receptor agonists and the pathophysiology of migraine","volume":"10","author":"Saxena","year":"1989","journal-title":"Trends Pharmacol Sci"},{"issue":"1\u20132","key":"10.1016\/j.bpa.2020.07.009_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pain.2005.03.008","article-title":"Where do triptans act in the treatment of migraine?","volume":"115","author":"Ahn","year":"2005","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.009_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S0317167100000147","article-title":"Pathophysiology of migraine \u2014 new insights","volume":"26","author":"Hargreaves","year":"1999","journal-title":"Can J Neurol Sci"},{"issue":"9294","key":"10.1016\/j.bpa.2020.07.009_bib25","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","article-title":"Oral triptans (serotonin 5-HT1B\/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials","volume":"358","author":"Ferrari","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1468-2982.1988.0802083.x","article-title":"Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache","volume":"8","author":"Markowitz","year":"1988","journal-title":"Cephalalgia"},{"issue":"Pt 1","key":"10.1016\/j.bpa.2020.07.009_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/123.1.9","article-title":"Ergotamine in the acute treatment of migraine: a review and European consensus","volume":"123","author":"Tfelt-Hansen","year":"2000","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.009_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/head.13456","article-title":"The American headache society position statement on integrating new migraine treatments into clinical practice","volume":"59","author":"American","year":"2019","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.009_bib29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/CON.0000000000000199","article-title":"Preventive migraine treatment","volume":"21","author":"Silberstein","year":"2015","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.009_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.009_bib31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/head.12055","article-title":"Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II)","volume":"53","author":"Blumenfeld","year":"2013","journal-title":"Headache"},{"issue":"17","key":"10.1016\/j.bpa.2020.07.009_bib32","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards subcommittee of the American academy of neurology and the American headache society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.009_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1468-2982.2008.01555.x","article-title":"Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults","volume":"28","author":"Silberstein","year":"2008","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.bpa.2020.07.009_bib34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/jamaneurol.2018.1212","article-title":"Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial","volume":"75","author":"Stauffer","year":"2018","journal-title":"JAMA Neurol"},{"issue":"22","key":"10.1016\/j.bpa.2020.07.009_bib35","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa1705848","article-title":"A\u00a0controlled trial of erenumab for episodic migraine","volume":"377","author":"Goadsby","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.009_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/187152707781387233","article-title":"Nitric oxide in migraine","volume":"6","author":"Neeb","year":"2008","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"March","key":"10.1016\/j.bpa.2020.07.009_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2018.03.059","article-title":"The role of nutrients in the pathogenesis and treatment of migraine headaches: Review","volume":"102","author":"Nattagh-Eshtivani","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.bpa.2020.07.009_bib38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10072-018-3286-5","article-title":"The association between serum vitamin B12 deficiency and tension-type headache in Turkish children","volume":"39","author":"Calik","year":"2018","journal-title":"Neurol Sci"},{"key":"10.1016\/j.bpa.2020.07.009_bib39","doi-asserted-by":"crossref","first-page":"469529","DOI":"10.1155\/2015\/469529","article-title":"Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine","volume":"2015","author":"Shaik","year":"2015","journal-title":"Biomed Res Int"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.009_bib40","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2174\/18715273113129990112","article-title":"Do folate, vitamins B6 and B12 play a role in the pathogenesis of migraine? The role of pharmacoepigenomics","volume":"13","author":"Shaik","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.009_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1067\/mpd.2001.112160","article-title":"Vitamin B12 deficiency in children and adolescents","volume":"138","author":"Rasmussen","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.009_bib42","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.semerg.2012.06.006","article-title":"Manifestaciones neurol\u00f3gicas por d\u00e9ficit aislado de vitamina B12","volume":"39","author":"Martinez Estrada","year":"2013","journal-title":"Semergen"},{"issue":"7","key":"10.1016\/j.bpa.2020.07.009_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1468-2982.2002.00412.x","article-title":"Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study","volume":"22","author":"Van Der Kuy","year":"2002","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.bpa.2020.07.009_bib44","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/head.13618","article-title":"Serum vitamin B12 and methylmalonic acid status in migraineurs: a case-control study","volume":"59","author":"Togha","year":"2019","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"issue":"3\u20134","key":"10.1016\/j.bpa.2020.07.009_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1615\/CritRevNeurobiol.v10.i3-4.20","article-title":"Neurobiology of nitric oxide","volume":"10","author":"Yun","year":"1996","journal-title":"Crit Rev Neurobiol"},{"issue":"11","key":"10.1016\/j.bpa.2020.07.009_bib47","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/01.RES.0000103311.52853.48","article-title":"Regulation of gene expression by cyclic GMP","volume":"93","author":"Pilz","year":"2003","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.009_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1476-5381.1993.tb13429.x","article-title":"Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle","volume":"108","author":"Rajanayagam","year":"1993","journal-title":"Br J Pharmacol"},{"issue":"6 30\u20136","key":"10.1016\/j.bpa.2020.07.009_bib49","article-title":"Reciprocal regulation by putatively nitroxidergic and adrenergic nerves of monkey and dog temporal arterial tone","volume":"261","author":"Toda","year":"1991","journal-title":"Am J Physiol Hear Circ Physiol"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.009_bib50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.ph.57.030195.003343","article-title":"Nitric oxide signaling in the central nervous system","volume":"57","author":"Garthwaite","year":"1995","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"10.1016\/j.bpa.2020.07.009_bib51","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00001756-199308000-00008","article-title":"Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain","volume":"4","author":"Olesen","year":"1993","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.bpa.2020.07.009_bib52","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/01.RES.70.6.1313","article-title":"Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles","volume":"70","author":"Wei","year":"1992","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib53","first-page":"19","article-title":"The role of homocysteine in the pathogenesis of migrane","volume":"4","author":"Pizza","year":"2013","journal-title":"Curr Neurobiol"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.009_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020498","article-title":"Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects","volume":"8","author":"Mahmoud","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.bpa.2020.07.009_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0083-6729(04)69011-X","article-title":"Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis","volume":"69","author":"Bianchi","year":"2004","journal-title":"Vitam Horm"},{"issue":"10","key":"10.1016\/j.bpa.2020.07.009_bib56","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1468-1331.2011.03414.x","article-title":"Oxidative stress is associated with migraine and migraine-related metabolic risk in females","volume":"18","author":"Bernecker","year":"2011","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(00)02260-2","article-title":"Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface","volume":"486","author":"Yamamoto","year":"2000","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.bpa.2020.07.009_bib58","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1526-4610.2010.01713.x","article-title":"A\u00a0remarkable increase in total homocysteine concentrations in the CSF of migraine patients with aura","volume":"50","author":"Isobe","year":"2010","journal-title":"Headache"},{"issue":"SUPPL. 1","key":"10.1016\/j.bpa.2020.07.009_bib59","article-title":"Homocysteine plasma levels in patients with migraine with aura","volume":"29","author":"Moschiano","year":"2008","journal-title":"Neurol Sci"},{"issue":"8","key":"10.1016\/j.bpa.2020.07.009_bib60","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1468-2982.2007.01400.x","article-title":"Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis","volume":"29","author":"Rubino","year":"2009","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.bpa.2020.07.009_bib61","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/head.12490","article-title":"Effects of dietary folate intake on migraine disability and frequency","volume":"55","author":"Menon","year":"2015","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.bpa.2020.07.009_bib62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5114\/ninp.2012.31354","article-title":"Frequency of the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene in patients with migraine with or without aura - a preliminary report","volume":"46","author":"Szczygio\u0142","year":"2012","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.009_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10072-017-3141-0","article-title":"Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran","volume":"39","author":"Martami","year":"2018","journal-title":"Neurol Sci"},{"issue":"10","key":"10.1016\/j.bpa.2020.07.009_bib64","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpa.2020.07.009_bib65","article-title":"Helicobacter pylori associated vitamin B12 deficiency, pernicious anaemia and subacute combined degeneration of the spinal cord","volume":"10\u20133","author":"Gowdappa","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"12","key":"10.1016\/j.bpa.2020.07.009_bib66","article-title":"Vitamin B12 ved migrene [Vitamin B12 therapy of headache]","volume":"71","author":"Urdahl-Aasen","year":"1951","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"7","key":"10.1016\/j.bpa.2020.07.009_bib67","first-page":"339","article-title":"Profylaktisk behandling af migraene med vitamin B12 [Prophylactic Treatment of Migraine with Vitamin B 12]","volume":"132","author":"Dalsgaard-Nielsen","year":"1970","journal-title":"Ugeskr Laeger"},{"issue":"4","key":"10.1016\/j.bpa.2020.07.009_bib68","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10194-005-0225-7","article-title":"Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache","volume":"6","author":"Trucco","year":"2005","journal-title":"J\u00a0Headache Pain"},{"issue":"10","key":"10.1016\/j.bpa.2020.07.009_bib69","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/FPC.0b013e3283576b6b","article-title":"Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation","volume":"22","author":"Menon","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"10.1016\/j.bpa.2020.07.009_bib70","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s10194-016-0652-7","article-title":"The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients","volume":"17","author":"Menon","year":"2016","journal-title":"J\u00a0Headache Pain"},{"issue":"3","key":"10.1016\/j.bpa.2020.07.009_bib71","first-page":"1","article-title":"C677T methylenetetrahydrofolate reductase homozygosis and vitamin supplement in migraineur children","volume":"12","author":"Tozzi","year":"2018","journal-title":"Int Neuropsychiatr Dis J"}],"container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:30:16Z","timestamp":1776425416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689620300641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1521689620300641"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2020.07.009","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of B12 for the treatment of chronic migraine","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2020.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}